Katsushige Ono Selected Research

Katsushige Ono Research Topics

Disease

6	Atrial Fibrillation 07/2022 - 07/2005
3	Hypertension (High Blood Pressure) 03/2024 - 06/2021
3	Cardiac Arrhythmias (Arrythmia) 12/2022 - 05/2009
3	Inflammation (Inflammations) 07/2022 - 01/2013
3	Heart Failure 06/2021 - 12/2007
2	Atherosclerosis 01/2022 - 01/2019
2	Right Ventricular Hypertrophy 09/2008 - 06/2006
1	Cardiotoxicity 01/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023
1	Neoplasms (Cancer) 01/2023
1	Fibrosis (Cirrhosis) 07/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Hemorrhage 01/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 06/2021
1	Hypoxia (Hypoxemia) 06/2021
1	Cardiomyopathies (Cardiomyopathy) 06/2021
1	Hypothyroidism 03/2021
1	Kearns-Sayre Syndrome 03/2019
1	Shock 03/2019
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2019
1	Reperfusion Injury 01/2019
1	Atrial Remodeling 05/2016
1	MYD88 Deficiency 01/2013
1	Ischemia 01/2010
1	Tachycardia (Tachyarrhythmias) 01/2010
1	Insulin Resistance 01/2010
1	Pulmonary Hypertension 09/2008
1	Disease Progression 09/2008
1	Infections 06/2007
1	Bradycardia 01/2007
1	Atrial Flutter (Flutter, Atrial) 07/2005

Drug/Important Bio-Agent (IBA)

2	MicroRNAs (MicroRNA)IBA 01/2022 - 05/2016
2	Phosphotransferases (Kinase)IBA 06/2021 - 10/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2013 - 09/2008
1	RNA (Ribonucleic Acid)IBA 03/2024
1	Antineoplastic Agents (Antineoplastics)IBA 01/2023
1	Potassium Channels (Potassium Channel)IBA 01/2023
1	Gemcitabine FDA Link 01/2023
1	Proteins (Proteins, Gene)FDA Link 07/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 07/2022
1	Angiotensin IIIBA 07/2022
1	1- hexadecyl- 2- acetyl- glycero- 3- phosphocholine (APRL)IBA 01/2022
1	RivaroxabanIBA 01/2022
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 10/2021
1	Small Interfering RNA (siRNA)IBA 06/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 06/2021
1	TropomyosinIBA 06/2021
1	GlycogenIBA 10/2020
1	Protein Kinase CIBA 10/2020
1	Coenzyme A (CoA)IBA 01/2019
1	Oxidoreductases (Dehydrogenase)IBA 01/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019
1	CholesterolIBA 01/2019
1	Uric Acid (Urate)IBA 01/2019
1	LipidsIBA 01/2019
1	Fluvastatin FDA Link 01/2019
1	perhydroxyl radicalIBA 01/2019
1	Pravastatin (Pravachol)FDA LinkGeneric 01/2019
1	GTP-Binding Proteins (G-Protein)IBA 05/2016
1	UbiquitinIBA 01/2013
1	Glucose (Dextrose)FDA LinkGeneric 01/2010
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2010
1	Type 1 Angiotensin ReceptorIBA 05/2009
1	Atrial Natriuretic Factor (ANF)IBA 09/2008
1	Sulfisoxazole (Sulfafurazole)FDA Link 09/2008
1	Endothelins (Endothelin)IBA 09/2008
1	SulfonamidesIBA 09/2008
1	Endothelin Receptors (Endothelin Receptor)IBA 09/2008
1	efonidipineIBA 12/2007
1	Transcription Factors (Transcription Factor)IBA 06/2007
1	CationsIBA 06/2007
1	Diltiazem (Cardizem)FDA LinkGeneric 01/2007
1	zatebradineIBA 01/2007
1	Propranolol (Inderal)FDA LinkGeneric 01/2007
1	MonocrotalineIBA 06/2006
1	Bepridil (Vascor)FDA Link 07/2005

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 12/2022 - 10/2022
1	Percutaneous Coronary Intervention 03/2021
1	Defibrillators (Defibrillator) 03/2019
1	Cardiac Resynchronization Therapy 03/2019
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 03/2019
1	Therapeutics 12/2007